Trial ID or NCT#

NCT01966458

Status

not recruiting iconNOT RECRUITING

Purpose

This is a prospective, randomized, controlled, unblinded, multi-center evaluation of safety and efficacy in patients implanted with a HeartWare® HVAD who receive improved blood pressure management. Subjects have chronic Stage D or NYHA Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible for cardiac transplantation.

Official Title

A Prospective, Randomized, Controlled, Unblinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Philip Oyer
Philip Oyer
Heart transplant surgeon
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus

Contact us to find out if this trial is right for you.

CONTACT

Ian Rogers
(650) 723-8138